IBX 2.50% 3.9¢ imagion biosystems limited

Ann: Appendix 4C - quarterly, page-36

  1. 6,209 Posts.
    lightbulb Created with Sketch. 1227
    Agree with the poster who suggested that medical staff ( as good as they are at their profession) are not necessarily the optimal one's to "market" the trial to prospective enrollees, or at least to set the parameters. Right now we have a marketing matter to resolve, not a medical matter, its as simple as that, and needs a marketing solution. In other words ... a compelling inducement to enrol. Everyone and everybody has a price... brutal as that may sound. We likely only need a handful of enrollees to demonstrate at least in preliminary terms if the technology is successful. Give them that inducement. Further down the track, with some initial positive results behind us, getting enrollees will then be an easier task. Its all about enrollees confidence. But we need an ice breaker first. The inducement

 
watchlist Created with Sketch. Add IBX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.